van Not, Olivier J.
~ 200  results:
Search for persons X
?
1

Time interval from primary melanoma to first distant recurr..:

van Duin, Isabella A J ; Elias, Sjoerd G ; van den Eertwegh, Alfonsus J M...
https://research.rug.nl/en/publications/0ce8ddfd-6e8a-4ebc-9ec2-ccbe0c0617e7.  , 2023
 
?
2

A Survival Tree of Advanced Melanoma Patients with Brain Me..:

van Not, Olivier J ; Wind, Thijs T ; Ismail, Rawa K...
https://research.rug.nl/en/publications/a56f7480-5347-4e43-a656-45e6e0822a98.  , 2023
 
?
3

Adjuvant treatment of in-transit melanoma:Narrowing the kno..:

de Meza, Melissa M ; Blokx, Willeke A M ; Bonenkamp, Han J...
https://research.rug.nl/en/publications/223288ae-e406-4242-9960-a4372d81f684.  , 2023
 
?
4

Is a History of Optimal Staging by Sentinel Lymph Node Biop..:

Blankenstein, Stephanie A ; Bonenkamp, Johannes J ; Aarts, Maureen J.B...
https://research.rug.nl/en/publications/bfbb12af-c547-4d79-8405-da26acd9adbc.  , 2023
 
?
5

ASO Visual Abstract:Is a History of Optimal Staging by SLNB..:

Blankenstein, Stephanie A ; Bonenkamp, Johannes J ; Aarts, Maureen J.B...
https://research.rug.nl/en/publications/4be038f0-bd3c-4161-8430-6307af0edb17.  , 2023
 
?
6

Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in St..:

De Meza, Melissa M ; Blokx, Willeke A.M ; Bonenkamp, Johannes J...
https://research.rug.nl/en/publications/2e7940ea-e7ca-49b8-bc64-e5aebd7b7636.  , 2023
 
?
8

Response to checkpoint inhibition and targeted therapy in m..:

Van Not, Olivier J ; van den Eertwegh, Alfons J M ; Haanen, John B...
https://research.rug.nl/en/publications/e972b5c2-4367-4512-8cbe-43460a094b37.  , 2023
 
?
9

Association of Immune-Related Adverse Event Management with..:

Van Not, Olivier J ; Verheijden, Rik J ; Van Den Eertwegh, Alfonsus J.M...
https://research.rug.nl/en/publications/de66de14-9e31-4f42-9448-66486c1ee1db.  , 2022
 
?
10

BRAF and NRAS Mutation Status and Response to Checkpoint In..:

van Not, Olivier J ; Blokx, Willeke A M ; van den Eertwegh, Alfons J M...
van Not , O J , Blokx , W A M , van den Eertwegh , A J M , de Meza , M M , Haanen , J B , Blank , C U , Aarts , M J B , van den Berkmortel , F W P J , de Groot , J W B , Hospers , G A P , Kapiteijn , E , Piersma , D , van Rijn , R S , Stevense-den Boer , M , van der Veldt , A A M , Boers-Sonderen , M J , Jansen , A M L , Wouters , M W J M & Suijkerbuijk , K P M 2022 , ' BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma ' , JCO Precision Oncology , vol. 6 , e2200018 . https://doi.org/10.1200/PO.22.00018 ; ISSN:2473-4284.  , 2022
 
?
 
?
12

Response to immune checkpoint inhibitors in acral melanoma:..:

van Not, Olivier J ; de Meza, Melissa M ; van den Eertwegh, Alfons J M...
https://research.rug.nl/en/publications/4eaf37d0-e9eb-444d-8275-f8aa051f3a33.  , 2022
 
?
14

The unfavorable effects of COVID-19 on Dutch advanced melan..:

van Not, Olivier J ; van Breeschoten, Jesper ; van den Eertwegh, Alfonsus J.M...
van Not , O J , van Breeschoten , J , van den Eertwegh , A J M , Hilarius , D L , De Meza , M M , Haanen , J B , Blank , C U , Aarts , M J B , van den Berkmortel , F W P J , de Groot , J W B , Hospers , G A P , Ismail , R K , Kapiteijn , E , Piersma , D , van Rijn , R S , Stevense-den Boer , M A M , van der Veldt , A A M , Vreugdenhil , G , Boers-Sonderen , M J , Blokx , W A M , Suijkerbuijk , K P M & Wouters , M W J M 2022 , ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ' , International Journal of Cancer , vol. 150 , no. 5 , pp. 816-824 . https://doi.org/10.1002/ijc.33833.  , 2022
 
?
15

Adjuvant treatment for melanoma in clinical practice - Tria..:

de Meza, Melissa M ; Ismail, Rawa K ; Rauwerdink, Daan...
https://research.rug.nl/en/publications/9a6d0a1e-2679-4f92-b2f0-d56557695be6.  , 2021
 
1-15